Cas:64175-51-5 2-(Benzofuran-3-yl)acetic acid manufacturer & supplier

We serve Chemical Name:2-(Benzofuran-3-yl)acetic acid CAS:64175-51-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(Benzofuran-3-yl)acetic acid

Chemical Name:2-(Benzofuran-3-yl)acetic acid
CAS.NO:64175-51-5
Synonyms:3-Benzofuranacetic acid;benzofuran-3-yl-acetic acid;2-(3-benzofuranyl)acetic acid;2-(benzofuran-3-yl)acetic acid;benzofuran-3-acetic acid;benzo<b>furan-3-acetic acid;BENZO[B]FURAN-3-YLACETIC ACID;2-(Benzofuran-3-yl)aceticacid;1-Benzofuran-3-ylacetic acid;3-benzofuranylacetic acid
Molecular Formula:C10H8O3
Molecular Weight:176.169
HS Code:2932999099

Physical and Chemical Properties:
Melting point:90ºC
Boiling point:331.1±17.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.628
PSA:50.44000
Exact Mass:176.047348
LogP:1.96

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Benzofuranacetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-benzofuranylacetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-benzofuranylacetic acid Use and application,1-Benzofuran-3-ylacetic acid technical grade,usp/ep/jp grade.


Related News: François-Henri Boissel, CEO of NOVA, commented: “Grégoire is an industry trail blazer with over two decades of experience in innovation, product strategy and digital entrepreneurship. N-(6,7-dimethoxyquinoxalin-5-yl)-N’,N’-diethylethane-1,2-diamine,phosphoric acid manufacturers Earlier this month, the drugmaker lifted a voluntary EU marketing hold on Zynteglo for beta thalassemia, after a patient death in one of the drugmaker’s other products, LentiGlobin, halted clinical studies. 7-chloro-N-(4-morpholin-4-ylbutan-2-yl)quinolin-4-amine,phosphoric acid suppliers Case in point: Hansoh Pharma is seeking approvals for its third-generation EGFR inhibitor Ameile (almonertinib) for newly diagnosed EGFR-mutated non-small cell lung cancer. 1-N,1-N-diethyl-4-N-(7-methoxy-2-phenylquinolin-4-yl)pentane-1,4-diamine vendor & factory.